TipRanks The Bottom Is in for These 2 Stocks? Analysts Say ‘Buy’ Today, we’re looking at two small-cap biotech firms whose stocks have struck a rut. Each company has hit a recent clinical setback that sent the share price falling, erasing previous gains and sending it back down to low levels. Setbacks of this sort are not uncommon in the biotech industry, and in fact highlight the risk and speculative nature of the industry. So what should investors do, when a stock collapses? Is this a… Source link
Read More »Flying taxi maker EHang shares rebound 40% after response to short-seller
